Pablo J. Cagnoni - 15 Oct 2026 Form 4 Insider Report for INCYTE CORP (INCY)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Oct 2026, 16:38:24 UTC
Prior SEC filing
17 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Filing notes and source

Key filing fact

Pablo J. Cagnoni filed Form 4 for INCYTE CORP (INCY) on 19 Oct 2026.

Key facts

  • This page summarizes Pablo J. Cagnoni's Form 4 filing for INCYTE CORP (INCY).
  • 9 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 19 Oct 2026, 16:38.

Change

  • Previous filing in this sequence was filed on 17 Sep 2026.
  • Current net transaction value: -$297,780.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001205703 Primary reporting owner

CAGNONI PABLO J

Relationship
President, Global Head of R&D
Address
1801 AUGUSTINE CUT-OFF, WILMINGTON
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Signature date
19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INCY transaction

Common Stock

Options Exercise

Transaction value
Shares
+839
Change %
+0.46%
Price
$71.93*
Shares after
184,039
Date
15 Oct 2026
Ownership
Direct
INCY transaction

Common Stock

Options Exercise

Transaction value
Shares
+423
Change %
+0.23%
Price
$61.76*
Shares after
184,462
Date
15 Oct 2026
Ownership
Direct
INCY transaction

Common Stock

Options Exercise

Transaction value
Shares
+455
Change %
+0.25%
Price
$61.18*
Shares after
184,917
Date
15 Oct 2026
Ownership
Direct
INCY transaction

Common Stock

Options Exercise

Transaction value
Shares
+925
Change %
+0.5%
Price
$64.25*
Shares after
185,842
Date
15 Oct 2026
Ownership
Direct
INCY transaction

Common Stock

Sale

Transaction value
-$297,780
Shares
-2,642
Change %
-1.4%
Price
$112.71
Shares after
183,200
Date
15 Oct 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-839
Change %
-4.5%
Price
$0.000000*
Shares after
17,627
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
839
Exercise price
$71.93
Footnotes
F2
INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-423
Change %
-10%
Price
$0.000000*
Shares after
3,802
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
423
Exercise price
$61.76
Footnotes
F3
INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-455
Change %
-10%
Price
$0.000000*
Shares after
4,096
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
455
Exercise price
$61.18
Footnotes
F4
INCY transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-925
Change %
-4.5%
Price
$0.000000*
Shares after
19,431
Date
15 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
925
Exercise price
$64.25
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

This includes an aggregate of 183,200 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance stock units that have not vested.

Footnote F2

Beginning January 17, 2025, options become exercisable in 37 installments, with the first 25% vesting on July 15, 2025 and the remainder vesting monthly over three years.

Footnote F3

The July 14, 2023 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Footnote F4

Beginning January 18, 2024, options become exercisable in 37 installments, with the first 25% vesting on July 14, 2024 and the remainder vesting monthly over three years.

Footnote F5

The July 15, 2024 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .